Sex differences in the clinical presentation and therapy of multiple sclerosis
Multiple sclerosis (MS) is more prevalent in women than in men, with the female to male ratio in the prevalence of MS constantly increasing. Besides, sex appears to affect the development, progression, clinical manifestation and therapy response in MS. These sex differences, most likely, emerge from...
Main Author: | Nacka-Aleksić Mirjana |
---|---|
Format: | Article |
Language: | srp |
Published: |
Pharmaceutical Association of Serbia, Belgrade, Serbia
2016-01-01
|
Series: | Arhiv za farmaciju |
Subjects: | |
Online Access: | https://scindeks-clanci.ceon.rs/data/pdf/0004-1963/2016/0004-19631604135N.pdf |
Similar Items
-
Relapsing-remitting multiple sclerosis: advances in disease-modifying therapies
by: Kay, Kathleen Alexandra
Published: (2016) -
Quality of life among injectable and oral disease-modifying therapy users in the Pacific Northwest Multiple Sclerosis Registry
by: Tamela Stuchiner, et al.
Published: (2020-12-01) -
Sex differences in brain atrophy in multiple sclerosis
by: Rhonda R. Voskuhl, et al.
Published: (2020-08-01) -
Monoclonal antibodies in the treatment of multiple sclerosis: from clinical research to practical application
by: N. Yu. Lashch
Published: (2020-07-01) -
Multiple sclerosis patients and COVID-19
by: Hubert Mado, et al.
Published: (2021-03-01)